Aims to achieve capital appreciation over the medium to longt-term and to produce a level of income yiled in excess of the FTSE All-Share index.
Name | % Net Assets |
---|---|
British Energy Group Plc | 7.4% |
BP Plc | 6.9% |
GlaxoSmithKline Plc | 6.8% |
British American Tobacco Plc | 5.8% |
Imperial Tobacco Group Plc | 4.8% |
AstraZeneca Plc | 4.8% |
Vodafone Group Plc | 4.6% |
BG Group Plc | 4.5% |
National Grid Plc | 4.5% |
Tesco Plc | 4.3% |
Key | % Net Assets |
---|---|
British Energy Group Plc | 7.4% |
BP Plc | 6.9% |
GlaxoSmithKline Plc | 6.8% |
British American Tobacco Plc | 5.8% |
Other | 73.1% |
Date | 09-Jul-2021 |
---|---|
Bid | 325.30p |
Offer | 342.40p |
Currency | GBP |
Change | -5.30p |
% | -1.57% |
YTD change | 333.85p |
YTD % | n/a |
Fund Inception | 02/01/1992 |
---|---|
Fund Manager | Neil Woodford |
TER | 1.86 |
Minimum Investment | |
---|---|
Initial | £1500 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.21 |
You are here: research